3D Systems (US) and Organovo Holdings, Inc. (US) are Leading Players in the 4D Printing in Healthcare Market
The global 4D printing in healthcare market is estimated to reach USD 32 million by 2026 from 9 million in 2021, at a CAGR of 29.9% during the forecast period. Growth in this market is driven mainly by technological advancements in 3D printing technology, such as the development of smart, programmable materials. On the other hand, high development & production costs, need for compliance with regulatory & performance standards that will slow product launches, and potential safety hazards are expected to restrain the growth of this market to a certain extent
The 4D printing in healthcare market is a highly diversified and competitive market, with a large number of players, including mid-tier companies and startup firms. 3D Systems (US), Organovo Holdings Inc. (US), Stratasys Ltd. (US & Israel), Dassault Systèmes (France), Materialise (Belgium), EOS GmbH Electro Optical Systems (Germany), EnvisionTEC (Germany), and Poietis (France) are some of the key players in the market. These players have adopted various growth strategies, such as product launches & upgrades; expansions; mergers & acquisitions; and partnerships, agreements, and collaborations; to further expand their presence in the global market.
To know about the assumptions considered for the study download the pdf brochure
Agreements, partnerships, and collaborations have been the key growth strategies adopted by players from 2016 to 2019. Some of the leading players who adopted these strategies include 3D Systems, Organovo Holdings, Inc., and Stratasys Ltd.
3D Systems (US)
3D Systems is one of the leading players in the 4D printing in healthcare market. With an extensive distribution network across the globe, 3D Systems has established itself as one of the leading players in the 3D printing market. The company focusses on providing unique and highly specialized products to meet its customer needs with optimal cost and performance. 3D printing solutions offered by the company enable its customers to design and manufacture complex and exclusive parts and also helps them to eliminate expensive tooling. To remain competitive in the global market, the company focuses on various inorganic growth strategies such as acquisitions, collaborations, and agreements to expand and enhance its portfolio of products, geographic reach, and client relationships. The company also focuses on organic growth strategies such as product launches to strengthen its presence in this highly competitive market.
Organovo Holdings, Inc. (US)
Organovo seeks to develop a technology platform for the generation of functional human tissues that can be employed in drug discovery & development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues & organs. The company focuses on the development of 3D bioprinted tissues for the treatment of severe liver diseases. NovoGen bioprinters provided by the company are an essential part of the tissue prototyping and manufacturing platform. Organovo focuses heavily on research collaborations with pharmaceutical, biotechnology & cosmetic companies; academic & research institutions; and government agencies. For instance, in May 2018, Organovo Holdings, Inc. and it’s wholly owned subsidiary Samsara Sciences, Inc. partnered with Advanced Regenerative Manufacturing Institute (‘ARMI’) to develop next-generation manufacturing processes and technologies for cells, tissues, and organs.
Stratasys Ltd. (US and Israel)
Stratasys is one of the leading providers of 3D printers and materials. Differentiated products with superior quality, integrated solutions offering, proprietary technology such as 3D FDM and 3D PolyJet, extensive global reach are the company’s key competitive strengths. The company has registered significant growth in the 3D printing market through its extensive distribution network. To enhance its position in the market, the company focuses on both organic as well as inorganic growth strategies. For instance, in February 2018, Stratasys collaborated with Dassault Systemes (France) and Unlimited Tomorrow Inc. (US) for 3D printing of prosthetics. Moreover, the company engages in R&D activities to develop novel systems and enhance its existing line of products. In this regard, the company invested USD 97.8 million, USD 96.2 million, and USD 99 million in the years 2016, 2017, and 2018, respectively, in research and development activities.
Related Reports:
4D Printing in Healthcare Market by Component (Equipment, 3D printer SMM, Hydrogels, Software, Service, Cells), Technology (FDM, SLS, Stereolithography), Application (Research Model, Implant), End user (Hospital, Dental Lab, ASC) - Global Forecast to 2026
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
